- 现金
- 6897 元
- 精华
- 8
- 帖子
- 2465
- 注册时间
- 2016-1-26
- 最后登录
- 2020-7-6
|
[size=0.8465em]Hepatology. 2018 Mar 13. doi: 10.1002/hep.29876. [Epub ahead of print]
Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine.[size=0.923em]Nishida N[size=0.8461em]1,[size=0.8461em]2, Sugiyama M[size=0.8461em]1, Sawai H[size=0.8461em]2, Nishina S[size=0.8461em]3, Sakai A[size=0.8461em]4, Ohashi J[size=0.8461em]5, Khor SS[size=0.8461em]2, Kakisaka K[size=0.8461em]6, Tsuchiura T[size=0.8461em]1, Hino K[size=0.8461em]3, Sumazaki R[size=0.8461em]4, Takikawa Y[size=0.8461em]6, Murata K[size=0.8461em]1,[size=0.8461em]7, Kanda T[size=0.8461em]8, Yokosuka O[size=0.8461em]8, Tokunaga K[size=0.8461em]2, Mizokami M[size=0.8461em]1.
[size=13.9997px]Author information
AbstractApproximately 5-10% of individuals, who are vaccinated with a hepatitis B (HB) vaccine designed based on the HBV genotype C, fail to acquire protective levels of antibodies. Here, host genetic factors behind low immune response to this HB vaccine were investigated by a genome wide association study (GWAS) and HLA association tests. A GWAS and HLA association tests were carried out using a total of 1,193 Japanese individuals including 107 low responders, 351 intermediate responders, and 735 high responders. Classical HLA class II alleles were statistically imputed using the genome-wide SNP typing data. The GWAS identified independent associations of HLA-DRB1-DQB1, HLA-DPB1 and BTNL2 genes with immune response to a HB vaccine designed based on the HBV genotype C. Five HLA-DRB1-DQB1 haplotypes and two DPB1 alleles showed significant associations with response to the HB vaccine in a comparison of three groups of 1,193 HB vaccinated individuals. When frequencies of DRB1-DQB1 haplotypes and DPB1 alleles were compared between low immune responders and HBV patients, significant associations were identified for three DRB1-DQB1 haplotypes, and no association was identified for any of the DPB1 alleles. In contrast, no association was identified for DRB1-DQB1 haplotypes and DPB1 alleles in a comparison between high immune responders and healthy individuals. The findings in this study clearly show the importance of HLA-DR-DQ (i.e. recognition of a vaccine related HB surface antigen (HBsAg) by specific DR-DQ haplotypes) and BTNL2 molecules (i.e. high immune response to HB vaccine) for response to a HB vaccine designed based on the HBV genotype C. This article is protected by copyright. All rights reserved.
[size=0.923em]KEYWORDS:GWAS; HBV; Vaccine; host genetic factors
|
|